SMTL ID : 6di5.1

CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH COVALENT INHIBITOR

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.42 Å

Oligo State

monomer

Ligands

1 x GJ7: 2-(4-phenoxyphenoxy)-6-[(1S,4S)-5-propanoyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyridine-3-carboxamide(Covalent)

GJ7.1: 15 residues within 4Å: Chain A: L.20, V.28, A.40, K.42, M.61, T.86, E.87, Y.88, M.89, C.93, R.137, L.140, S.150, D.151, F.152 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.20, A:K.42, A:T.86, A:L.140 Hydrogen bonds: A:T.86, A:E.87, A:M.89 pi-Stacking: A:F.152

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.2: 2 residues within 4Å: Chain A: T.15, F.16 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:F.16

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Qiu, H. et al., Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit. Bioorg. Med. Chem. Lett. (2018)

Release Date

2018-09-05

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence